NS
Nicholas A Saccomano
President and CEO

Nicholas A Saccomano insider trades: OnKure Therapeutics (OKUR) stock sales

President and CEO, OnKure Therapeutics Last trade Sep 21, 2026 25 Form 4 filings
$1K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2019
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Nicholas reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 21, 2026OKUR↓ Sell$259
Jun 22, 2026OKUR↓ Sell$378
Mar 23, 2026OKUR↓ Sell$357
Dec 22, 2025OKUR↓ Sell$258
Sep 22, 2025OKUR↓ Sell$231
Jun 23, 2025OKUR↓ Sell$210
Apr 7, 2025OKUR↓ Sell$3K
Feb 7, 2019ARRY↓ Sell$4.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other OKUR insiders

Open-market trades in the last 12 months

About Nicholas A Saccomano's insider trades

Nicholas A Saccomano is President and CEO at OnKure Therapeutics (OKUR). Since Feb 7, 2019, Nicholas has reported no open-market purchases and 8 sales worth $4.0M on SEC Form 4. In the last 12 months: 4 sales ($1K).

Their filings also include grants and awards (10 filings), option exercises (9 filings), shares withheld for taxes (9 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OKUR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.